Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 77015

Sort by

Sort Order Select

Journal Articles

PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study

Blood blood.2025028848.

https://doi.org/10.1182/blood.2025028848

Published: 2025

Journal Articles

Thrombocytopenia in myelofibrosis is characterized by inflammatory megakaryocytes with reduced G6B expression

Lilian Varricchio, Gohar Mosoyan, Sebastian Elghaity-Beckley, Md. Babu Mia, Shivani Handa, Christian Salib, John Mascarenhas, Ronald Hoffman

Blood (2025) 146 (13): 1612–1624.

https://doi.org/10.1182/blood.2024027363

Published: 2025

Includes: Supplemental data

Journal Articles

Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial

Blood blood.2025028823.

https://doi.org/10.1182/blood.2025028823

Published: 2025

Includes: Supplemental data

Journal Articles

Correlates and consequences of clonal hematopoiesis expansion rate: a 16-year longitudinal study of 6976 women

Blood (2025) 146 (9): 1078–1087.

https://doi.org/10.1182/blood.2025028417

Published: 2025

Includes: Supplemental data

Journal Articles

Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab

Blood blood.2025029117.

https://doi.org/10.1182/blood.2025029117

Published: 2025

Includes: Supplemental data

Journal Articles

Cyclophosphamide mitigates non-ICANS neurotoxicities following ciltacabtagene autoleucel treatment

Viktoria Blumenberg, Benjamin R. Puliafito, Charlotte E. Graham, Mark B. Leick, Md. Raihan Chowdhury, Maxx King, Deshea L. Harris, Noopur S. Raje, Andrew R. Branagan, Andrew J. Yee, Diana Cirstea, Kathleen M. E. Gallagher, Jörg Dietrich, Marcela V. Maus, Matthew J. Frigault

Blood (2025) 145 (23): 2788–2793.

https://doi.org/10.1182/blood.2024028172

Published: 2025

Includes: Supplemental data

Journal Articles

JAK2 -mutant clonal hematopoiesis is associated with venous thromboembolism

Rebecca L. Zon, Aswin Sekar, Katharine Clapham, Ohad Oren, Abhishek Niroula, Alexander G. Bick, Christopher J. Gibson, Gabriel Griffin, Md Mesbah Uddin, Donna Neuberg, Pradeep Natarajan, Benjamin L. Ebert

Blood (2024) 144 (20): 2149–2154.

https://doi.org/10.1182/blood.2024024187

Published: 2024

Includes: Supplemental data

Journal Articles

Association of Clonal Hematopoiesis of Indeterminate Potential (CHIP) with Incidence of Venous Thromboembolism Varies By Age: The Atherosclerosis Risk in Communities Study

Seyedmohammad Saadatagah, Rockbum Kim, Senthil Sukumar, Md Mesbah Uddin, Aaron R. Folsom, Mary Cushman, Weihong Tang, Pradeep Natarajan, Christie M. Ballantyne, Pamela Lutsey, Ang Li

Blood (2024) 144 (Supplement 1): 13.

https://doi.org/10.1182/blood-2024-198837

Published: 2024

Journal Articles

26S Proteasome Non-Atpase Subunit 3 (PSMD3/Rpn3) Is a Potential Therapeutic Target in Multiple Myeloma

Teng Fang, Yan Song, Ting Du, Arghya Ray, Xueping Wan, Minxing Wang, Sindhu C Pillai, Md. Abu Musa, Mu Hao, Lugui Qiu, Dharminder Chauhan, Kenneth C. Anderson

Blood (2024) 144 (Supplement 1): 1905.

https://doi.org/10.1182/blood-2024-206000

Published: 2024

Journal Articles

Molecular Consequences and Targeting of PPM1D Mutations and Overexpression in Myeloproliferative Neoplasm Stem Cells

Cara Clementelli, MD Babu Mia, Sarah Haines, Christoph Schaniel, Malgorzata Olszewska, Joann Arandela, Sebastian Elghaity-beckley, Sophie Klingborg, Zinedine Hoque, Min Lu, Eirini Papapetrou, Ronald Hoffman, Bridget Kelly Marcellino

Blood (2024) 144 (Supplement 1): 873.

https://doi.org/10.1182/blood-2024-204136

Published: 2024

Journal Articles

Mutation-Specific Differences in the Relationship between Obesity and Clonal Hematopoiesis, with a Focus on JAK2 V617F and MPN Prevention

Blood (2024) 144 (Supplement 1): 872.

https://doi.org/10.1182/blood-2024-204211

Published: 2024

Journal Articles

Selinexor Depletes Ruxolitinib Refractory Myelofibrosis Hematopoietic Stem Cells By Inducing Apoptosis and Blunting the Pro-Inflammatory Milieu

Min Lu, MD Babu Mia, Lijuan Xia, Andrea Ellero, Christopher J. Walker, Ronald Hoffman

Blood (2024) 144 (Supplement 1): 1377.

https://doi.org/10.1182/blood-2024-205114

Published: 2024

Journal Articles

Role of HMGA2 Overexpression Caused By Specific Genetic HMGA2 Aberrations in Disease Progression in Calreticulin-Mutated Myelofibrosis Patients

Christoph Schaniel, Shivani Handa, Joseph Tripodi, MD Babu Mia, Christian Salib, Jeff Vierstra, Allison J Cote, Daiva Ahire, Douglas Tremblay, Bridget Kelly Marcellino, John A Stamatoyannopoulos, Vesna Najfeld, Ronald Hoffman

Blood (2024) 144 (Supplement 1): 4512.

https://doi.org/10.1182/blood-2024-205834

Published: 2024

Journal Articles

Full Spectrum Multi-Parameter Single-Tube Flow Cytometry Analysis for Cross-Sectional Immune-Profiling of Natural Killer Cells in Multiple Myeloma Clinical Samples

Arghya Ray, Yan Song, Ting Du, Leutz Buon, Md. Abu Musa, Xueping Wan, Sindhu C Pillai, Teng Fang, Minxing Wang, Dharminder Chauhan, Kenneth C. Anderson

Blood (2024) 144 (Supplement 1): 1947.

https://doi.org/10.1182/blood-2024-204964

Published: 2024

Journal Articles

Combined Use of Ziftomenib and Selinexor Is Effective in NPM1 Mutant Acute Myeloid Leukemia

Sandhya Dhiman, Md. Hafiz Uddin, Vikram Dhillon, Jeff Justin Aguilar, Amro Aboukameel, Husain Khan, Sahar Bannoura, Jay Yang, Gregory Dyson, Steven Buck, Asfar Azmi, Lisa Polin, Francis Burrows, Linda Kessler, Jaroslaw Maciejewski, Suresh Kumar Balasubramanian

Blood (2024) 144 (Supplement 1): 2768.

https://doi.org/10.1182/blood-2024-206075

Published: 2024

Journal Articles

Proteasome Shuttle Factor and DNA Repair Protein Rad23A Is a Potential Therapeutic Target in Multiple Myeloma

Xueping Wan, Yan Song, Ting Du, Arghya Ray, Teng Fang, Minxing Wang, Sindhu C Pillai, Md. Abu Musa, Kenneth Wen, Dharminder Chauhan, Kenneth C. Anderson

Blood (2024) 144 (Supplement 1): 1896.

https://doi.org/10.1182/blood-2024-203535

Published: 2024

Journal Articles

Transcriptomic Analysis of αCD19 CAR T Cells Reveals Venetoclax-Induced Changes in T Cell Quality and Function

Taylor K Mandeville, Jacob P Wright, Cory Mavis, Matthew J. Cortese, MD, MPH, Spencer Rosario, Scott Olejniczak, Francisco Hernandez-Ilizaliturri

Blood (2024) 144 (Supplement 1): 1036.

https://doi.org/10.1182/blood-2024-212101

Published: 2024

Journal Articles

Clinical Outcomes of Transformed Follicular Lymphoma with CAR T-Cell Therapy: A US Multicenter Real-World Analysis

Blood (2024) 144 (Supplement 1): 525.

https://doi.org/10.1182/blood-2024-212106

Published: 2024

Journal Articles

Multiomic Evaluation of Immunologic Changes in Chronic Lymphocytic Leukemia with Venetoclax Treatment

Matthew J. Cortese, MD, MPH, Jacob P Wright, Cory Mavis, Taylor K Mandeville, Alex Niu, Dae-Kyum Kim, Spencer Rosario, Francisco Hernandez-Ilizaliturri

Blood (2024) 144 (Supplement 1): 78.

https://doi.org/10.1182/blood-2024-212019

Published: 2024

Journal Articles

iPSC-Derived CAR Neutrophils Possess Potent Activity Against Solid Tumors In Vivo

Aditi Majumder, MD Ehsanul Kabir, Ho Sun Jung, Yuju Jun, Jue Zhang, Anna Huttenlocher, Christian Capitini, James Thomson, Igor Slukvin

Blood (2024) 144 (Supplement 1): 86.

https://doi.org/10.1182/blood-2024-205135

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study

Thrombocytopenia in myelofibrosis is characterized by inflammatory megakaryocytes with reduced G6B expression

Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial

Correlates and consequences of clonal hematopoiesis expansion rate: a 16-year longitudinal study of 6976 women

Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab

Cyclophosphamide mitigates non-ICANS neurotoxicities following ciltacabtagene autoleucel treatment

JAK2 -mutant clonal hematopoiesis is associated with venous thromboembolism

Association of Clonal Hematopoiesis of Indeterminate Potential (CHIP) with Incidence of Venous Thromboembolism Varies By Age: The Atherosclerosis Risk in Communities Study

26S Proteasome Non-Atpase Subunit 3 (PSMD3/Rpn3) Is a Potential Therapeutic Target in Multiple Myeloma

Molecular Consequences and Targeting of PPM1D Mutations and Overexpression in Myeloproliferative Neoplasm Stem Cells

Mutation-Specific Differences in the Relationship between Obesity and Clonal Hematopoiesis, with a Focus on JAK2 V617F and MPN Prevention

Selinexor Depletes Ruxolitinib Refractory Myelofibrosis Hematopoietic Stem Cells By Inducing Apoptosis and Blunting the Pro-Inflammatory Milieu

Role of HMGA2 Overexpression Caused By Specific Genetic HMGA2 Aberrations in Disease Progression in Calreticulin-Mutated Myelofibrosis Patients

Full Spectrum Multi-Parameter Single-Tube Flow Cytometry Analysis for Cross-Sectional Immune-Profiling of Natural Killer Cells in Multiple Myeloma Clinical Samples

Combined Use of Ziftomenib and Selinexor Is Effective in NPM1 Mutant Acute Myeloid Leukemia

Proteasome Shuttle Factor and DNA Repair Protein Rad23A Is a Potential Therapeutic Target in Multiple Myeloma

Transcriptomic Analysis of αCD19 CAR T Cells Reveals Venetoclax-Induced Changes in T Cell Quality and Function

Clinical Outcomes of Transformed Follicular Lymphoma with CAR T-Cell Therapy: A US Multicenter Real-World Analysis

Multiomic Evaluation of Immunologic Changes in Chronic Lymphocytic Leukemia with Venetoclax Treatment

iPSC-Derived CAR Neutrophils Possess Potent Activity Against Solid Tumors In Vivo

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only